{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:19:14Z","timestamp":1792081154631,"version":"4.4.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jacc.2017.09.1064","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T14:16:33Z","timestamp":1509372993000},"page":"2393-2410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics"],"prefix":"10.1016","volume":"70","author":[{"given":"Sanjay","family":"Divakaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Loscalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.09.1064_bib1","series-title":"Some account of a disorder of the breast. Medical Transactions. London: Royal College of Physicians","first-page":"59","author":"Heberden","year":"1772"},{"key":"10.1016\/j.jacc.2017.09.1064_bib2","series-title":"Experiments and observations on different kinds of air. 2nd ed","author":"Priestley","year":"1775"},{"key":"10.1016\/j.jacc.2017.09.1064_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMsr1503311","article-title":"Nitroglycerin and nitric oxide\u2014a rondo of themes in cardiovascular therapeutics","volume":"373","author":"Steinhorn","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1440-1681.2000.03240.x","article-title":"A\u00a0short history of nitroglycerine and nitric oxide in pharmacology and physiology","volume":"27","author":"Marsh","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198700334-00003","article-title":"Historical aspects of nitrate therapy","volume":"33 Suppl 4","author":"Berlin","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2017.09.1064_bib6","first-page":"245","article-title":"Contributions to the knowledge of the amyl group. 1. Nitryl of amyl and its derivatives","volume":"11","author":"Guthrie","year":"1859","journal-title":"J\u00a0Chem Soc"},{"key":"10.1016\/j.jacc.2017.09.1064_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.CIR.74.2.222","article-title":"T.\u00a0Lauder Brunton and amyl nitrite: a Victorian vasodilator","volume":"74","author":"Fye","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(02)51392-1","article-title":"On the use of nitrite of amyl in angina pectoris","volume":"2","author":"Brunton","year":"1867","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"Nitro-glycerine as a remedy for angina pectoris","volume":"113","author":"Murrell","year":"1879","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1139\/y75-153","article-title":"Effects of potassium chloride and smooth muscle relaxants on tension and cyclic nucleotide levels in rat myometrium","volume":"53","author":"Diamond","year":"1975","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0026-895X(25)10811-0","article-title":"Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery","volume":"12","author":"Diamond","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)11207-8","article-title":"Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle","volume":"13","author":"Katsuki","year":"1977","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib14","first-page":"23","article-title":"Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine","volume":"3","author":"Katsuki","year":"1977","journal-title":"J\u00a0Cyclic Nucleotide Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2017.09.1064_bib16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1073\/pnas.79.6.2106","article-title":"Role of endothelial cells in relaxation of isolated arteries by bradykinin","volume":"79","author":"Cherry","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.65.1.1","article-title":"Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein","volume":"65","author":"Ignarro","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib18","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.RES.61.6.866","article-title":"Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical","volume":"61","author":"Ignarro","year":"1987","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2017.09.1064_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCRESAHA.113.301577","article-title":"The identification of nitric oxide as endothelium-derived relaxing factor","volume":"113","author":"Loscalzo","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib22","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox-activated forms","volume":"258","author":"Stamler","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jacc.2017.09.1064_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","article-title":"Vascular nitric oxide: Beyond eNOS","volume":"129","author":"Zhao","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jacc.2017.09.1064_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ars.2007.1959","article-title":"Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective","volume":"10","author":"Chen","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacc.2017.09.1064_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","article-title":"Enzymatic function of nitric oxide synthases","volume":"43","author":"Andrew","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib28","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1096\/fj.02-0155fje","article-title":"Vasculoprotective roles of neuronal nitric oxide synthase","volume":"16","author":"Morishita","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib29","doi-asserted-by":"crossref","first-page":"29541","DOI":"10.1074\/jbc.270.49.29541","article-title":"The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B","volume":"270","author":"Spink","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib30","doi-asserted-by":"crossref","first-page":"18596","DOI":"10.1074\/jbc.271.31.18596","article-title":"Mechanism of nitric oxide release from S-nitrosothiols","volume":"271","author":"Singh","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib31","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1172\/JCI117480","article-title":"In\u00a0vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols","volume":"94","author":"Scharfstein","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3565(24)37255-6","article-title":"S-transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide","volume":"284","author":"Liu","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/01.ATV.0000217632.98717.a0","article-title":"Nitric oxide and posttranslational modification of the vascular proteome: S-nitrosation of reactive thiols","volume":"26","author":"Handy","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1172\/JCI24650","article-title":"Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control","volume":"115","author":"Huang","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib35","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.1074\/jbc.M511803200","article-title":"Characterization of the mechanism of cytochrome P450 reductase-cytochrome P450-mediated nitric oxide and nitrosothiol generation from organic nitrates","volume":"281","author":"Li","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/ars.2012.4744","article-title":"S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system","volume":"18","author":"Maron","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacc.2017.09.1064_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0015-6264(76)80005-3","article-title":"Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in\u00a0vivo formation of N-nitroso compounds","volume":"14","author":"Spiegelhalder","year":"1976","journal-title":"Food Cosmet Toxicol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2017.09.1064_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2016.12.015","article-title":"Enterosalivary nitrate metabolism and the microbiome: intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health","volume":"105","author":"Koch","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K","article-title":"Molecular mechanism of cGMP-mediated smooth muscle relaxation","volume":"184","author":"Carvajal","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1152\/advances.2003.27.4.201","article-title":"Smooth muscle contraction and relaxation","volume":"27","author":"Webb","year":"2003","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.jacc.2017.09.1064_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molcel.2010.07.013","article-title":"S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability","volume":"39","author":"Thibeault","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jacc.2017.09.1064_bib43","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1172\/JCI119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib44","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI119451","article-title":"Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis","volume":"99","author":"Ziche","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib45","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","article-title":"Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability","volume":"98","author":"Fukumura","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI112024","article-title":"N-acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin","volume":"76","author":"Loscalzo","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib47","doi-asserted-by":"crossref","first-page":"19028","DOI":"10.1016\/S0021-9258(17)30619-1","article-title":"Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine","volume":"265","author":"Mendelsohn","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib48","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1074\/jbc.274.20.14368","article-title":"Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets","volume":"274","author":"Pigazzi","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib49","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.CIR.83.6.2122","article-title":"Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries","volume":"83","author":"Folts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib50","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"F\u00f6rstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0895-7061(01)02317-2","article-title":"Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals","volume":"15","author":"Higashi","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2017.09.1064_bib52","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2017.09.1064_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199802193380807","article-title":"Nitrate therapy for stable angina pectoris","volume":"338","author":"Parker","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/9.suppl_A.33","article-title":"Pharmacokinetics of organic nitrates in man: an overview","volume":"9 Suppl A","author":"Bogaert","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-016-6668-z","article-title":"Vasodilator therapy: nitrates and nicorandil","volume":"30","author":"Tarkin","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib56","doi-asserted-by":"crossref","first-page":"4B","DOI":"10.1016\/0002-9149(92)90588-P","article-title":"Biochemical mechanism of organic nitrate action","volume":"70","author":"Fung","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacc.2017.09.1064_bib58","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/ATVBAHA.112.254011","article-title":"P300\/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(\u03b5)-lysine acetylation of contractile proteins","volume":"32","author":"Colussi","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11897-014-0230-8","article-title":"Impact of intravenous nitroglycerin in the management of acute decompensated heart failure","volume":"12","author":"den Uil","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2017.09.1064_bib60","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/01.CIR.66.6.1273","article-title":"Arterial-venous nitroglycerin gradient during intravenous infusion in man","volume":"66","author":"Armstrong","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0002-9149(87)91087-3","article-title":"Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris","volume":"59","author":"Thadani","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurheartj\/eht384","article-title":"Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"35","author":"M\u00fcnzel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib63","doi-asserted-by":"crossref","first-page":"18J","DOI":"10.1016\/0002-9149(89)90200-2","article-title":"Nicorandil as a hybrid between nitrates and potassium channel activators","volume":"63","author":"Taira","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib64","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00005344-199206203-00008","article-title":"Pharmacokinetic profile of nicorandil in humans: an overview","volume":"20 Suppl 3","author":"Frydman","year":"1992","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2005.06.053","article-title":"The effect of the K+ agonist nicorandil on peripheral vascular resistance","volume":"111","author":"Brodmann","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-199510000-00006","article-title":"Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels","volume":"26","author":"Akai","year":"1995","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib67","doi-asserted-by":"crossref","first-page":"25J","DOI":"10.1016\/0002-9149(89)90201-4","article-title":"Pharmacokinetics of nicorandil","volume":"63","author":"Frydman","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib68","first-page":"152","article-title":"Sodium nitroprusside: twenty years and counting","volume":"81","author":"Friederich","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2017.09.1064_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-3565(25)30018-2","article-title":"Nitroprusside produces cyanide poisoning via reaction with hemoglobin","volume":"191","author":"Smith","year":"1974","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004311-197816020-00003","article-title":"Sodium nitroprusside: metabolism and general considerations","volume":"16","author":"Ivankovich","year":"1978","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.jacc.2017.09.1064_bib71","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1161\/01.CIR.0000134595.80170.62","article-title":"Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential","volume":"109","author":"Ichinose","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/smll.201200458","article-title":"Nitric oxide donors for cardiovascular implant applications","volume":"9","author":"Naghavi","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.jacc.2017.09.1064_bib73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/cr000028t","article-title":"Chemistry of the nitric oxide-releasing diazeniumdiolate (\u201cnitrosohydroxylamine\u201d) functional group and its oxygen-substituted derivatives","volume":"102","author":"Hrabie","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.jacc.2017.09.1064_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1538574408322752","article-title":"Basic science review: nitric oxide\u2014releasing prosthetic materials","volume":"43","author":"Varu","year":"2009","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jacc.2017.09.1064_bib75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/cs0980507","article-title":"S-Nitrosothiols: a class of nitric oxide-donor drugs","volume":"98","author":"Al-Sa'doni","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2017.09.1064_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/092986710789957841","article-title":"Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks","volume":"17","author":"Scatena","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib77","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/092986712803414321","article-title":"Nitric oxide: state of the art in drug design","volume":"19","author":"Serafim","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib78","series-title":"Nitrite and Nitrate in Human Health and Disease","first-page":"349","article-title":"Pharmacology of nitrovasodilators","author":"Munzel","year":"2017"},{"key":"10.1016\/j.jacc.2017.09.1064_bib79","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1073\/pnas.122225199","article-title":"Identification of the enzymatic mechanism of nitroglycerin bioactivation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib80","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1161\/01.RES.0000100067.62876.50","article-title":"Does nitric oxide mediate the vasodilator activity of nitroglycerin?","volume":"93","author":"Kleschyov","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib81","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1476-5381.1995.tb17236.x","article-title":"Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in\u00a0vivo","volume":"116","author":"M\u00fclsch","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib82","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"M\u00fcnzel","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00392-007-0588-7","article-title":"New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance","volume":"97","author":"Daiber","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-12-385061-4.00007-6","article-title":"Organic nitrates and nitrate tolerance\u2014state of the art and future developments","volume":"60","author":"Daiber","year":"2010","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9149(71)90083-X","article-title":"The effect of nitroglycerin on coronary blood flow and the hemodynamic response to exercise in coronary artery disease","volume":"27","author":"Parker","year":"1971","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib86","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0002-9149(75)90889-9","article-title":"Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment","volume":"36","author":"Greenberg","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib87","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.CIR.64.6.1089","article-title":"The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response","volume":"64","author":"Brown","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0002-9149(72)90623-6","article-title":"Clinical response to nitroglycerin as a diagnostic test for coronary artery disease","volume":"29","author":"Horwitz","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.CIR.49.2.298","article-title":"Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations","volume":"49","author":"Goldstein","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.RES.15.4.355","article-title":"Effect of coronary vasodilator drugs on retrograde flow in areas of chronic myocardial ischemia","volume":"15","author":"Fam","year":"1964","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib91","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.87.5.1461","article-title":"The nitrovasodilators. New ideas about old drugs","volume":"87","author":"Harrison","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/cvr\/1.2.101","article-title":"Platelet behaviour and drugs used in cardiovascular disease","volume":"1","author":"Hampton","year":"1967","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib93","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V55.4.649.649","article-title":"Inhibition of platelet function by organic nitrate vasodilators","volume":"55","author":"Schafer","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2017.09.1064_bib94","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/0002-9149(92)90590-U","article-title":"Antiplatelet and antithrombotic effects of organic nitrates","volume":"70","author":"Loscalzo","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib95","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biopha.2016.11.125","article-title":"Therapeutic role of nitric oxide as emerging molecule","volume":"85","author":"Kumar","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacc.2017.09.1064_bib96","first-page":"G572","article-title":"Nitric oxide. II. Nitric oxide protects in intestinal inflammation","volume":"276","author":"Lefer","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib97","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.4049\/jimmunol.166.5.3067","article-title":"Stromal cell-derived factor 1 alpha-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways","volume":"166","author":"Cherla","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib98","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0192-0561(00)00045-X","article-title":"Nitric oxide induces chemotaxis of neutrophil-like HL-60 cells and translocation of cofilin to plasma membranes","volume":"22","author":"Adachi","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib99","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0076-6879(96)69044-2","article-title":"Nitric oxide as antiinflammatory agent","volume":"269","author":"Granger","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/CH-2008-1081","article-title":"The mechanism of nitrate-induced preconditioning","volume":"39","author":"Gori","year":"2008","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jacc.2017.09.1064_bib101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2125.2007.02864.x","article-title":"Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight","volume":"64","author":"Gori","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2796.1998.00253.x","article-title":"Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study","volume":"243","author":"Karlberg","year":"1998","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib103","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.67.2.276","article-title":"Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial","volume":"67","author":"Curfman","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib104","first-page":"1115","article-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0735-1097(95)00498-X","article-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial","volume":"27","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib106","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib107","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(88)91906-X","article-title":"Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials","volume":"1","author":"Yusuf","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.CIR.67.1.124","article-title":"Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris","volume":"67","author":"Kimchi","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib109","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(63)91802-6","article-title":"Glyceryl trinitrate in angina pectoris","volume":"1","author":"Sandler","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-8703(75)90226-4","article-title":"Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design","volume":"90","author":"Winsor","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.50.2.348","article-title":"Sustained effects of nitroglycerin ointment in patients with angina pectoris","volume":"50","author":"Reichek","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0167-5273(91)90331-I","article-title":"Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group","volume":"32","author":"Scardi","year":"1991","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib113","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00052566","article-title":"The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time\u2014a meta-analysis","volume":"6","author":"Klemsdal","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9149(84)90296-0","article-title":"Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy","volume":"54","author":"Parker","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-105-4-485","article-title":"Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance","volume":"105","author":"Thadani","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib116","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0735-1097(89)90216-7","article-title":"Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina","volume":"13","author":"DeMots","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib117","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.09.1064_bib118","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.108.843474","article-title":"Coronary artery spasm: a 2009 update","volume":"119","author":"Stern","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib119","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/eurheartj\/14.6.845","article-title":"Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study","volume":"14","author":"Lombardi","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib120","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2015.02.038","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib121","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/eurheartj\/ehv755","article-title":"Agents with vasodilator properties in acute heart failure","volume":"38","author":"Singh","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib122","first-page":"CD005151","article-title":"Nitrates for acute heart failure syndromes","author":"Wakai","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2017.09.1064_bib123","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib124","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib125","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib126","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","article-title":"Inhaled therapies for pulmonary hypertension","volume":"60","author":"Hill","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.jacc.2017.09.1064_bib127","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2017.09.1064_bib128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension","volume":"170","author":"Kinsella","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2017.09.1064_bib129","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2017.09.1064_bib130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40256-014-0072-5","article-title":"Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance","volume":"14","author":"Thadani","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2017.09.1064_bib131","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.61.3.526","article-title":"Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate","volume":"61","author":"Thadani","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib132","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9149(82)90518-5","article-title":"Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy","volume":"49","author":"Thadani","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib133","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9149(91)90229-E","article-title":"Steering Committee, Transdermal Nitroglycerin Cooperative Study. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin","volume":"68","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib134","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9149(84)90233-9","article-title":"Transdermal nitroglycerin in angina pectoris","volume":"54","author":"Parker","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00877416","article-title":"Ointments and transdermal nitroglycerin patches for stable angina pectoris","volume":"8","author":"Thadani","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib136","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00877415","article-title":"Short and long-acting oral nitrates for stable angina pectoris","volume":"8","author":"Thadani","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib137","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0002-9149(93)90292-K","article-title":"Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris","volume":"72","author":"Chrysant","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib138","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.CIR.77.6.1376","article-title":"Antianginal effects of intravenous nitroglycerin over 24 hours","volume":"77","author":"Zimrin","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib139","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vph.2014.09.002","article-title":"Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction","volume":"63","author":"M\u00fcnzel","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib140","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1073\/pnas.92.11.5244","article-title":"Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance","volume":"92","author":"M\u00fcnzel","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib141","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehs100","article-title":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression","volume":"34","author":"Oelze","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib142","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(88)90066-0","article-title":"Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses","volume":"158","author":"M\u00fclsch","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib143","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005344-198710000-00001","article-title":"Effect of in\u00a0vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta","volume":"10","author":"Molina","year":"1987","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib144","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib145","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI200419267","article-title":"Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance","volume":"113","author":"Sydow","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib146","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/mol.104.002600","article-title":"Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates","volume":"66","author":"Daiber","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib147","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1074\/jbc.M606477200","article-title":"Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance","volume":"282","author":"Wenzel","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib148","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/hc3501.095358","article-title":"Folic acid\u00a0prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in\u00a0vivo study","volume":"104","author":"Gori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib149","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2003.07.009","article-title":"Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance","volume":"42","author":"Hink","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib150","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0735-1097(02)02133-2","article-title":"Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits","volume":"40","author":"Warnholtz","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib151","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance","volume":"104","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib152","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.84.6.2336","article-title":"Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin","volume":"84","author":"Parker","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib153","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF00053031","article-title":"Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure","volume":"10","author":"Thadani","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib154","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/01.CIR.83.4.1271","article-title":"Prevention of nitrate tolerance with angiotension converting enzyme inhibitors","volume":"83","author":"Katz","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/clc.21993","article-title":"Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics","volume":"35","author":"Boden","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib156","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9149(90)90489-N","article-title":"Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease","volume":"66","author":"Dakak","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib157","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0735-1097(10)80342-0","article-title":"Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine","volume":"16","author":"Dupuis","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib158","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.79.1.188","article-title":"Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in\u00a0vivo, but tolerance-independent interactions exist","volume":"79","author":"M\u00fcnzel","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib159","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.CIR.76.3.572","article-title":"Nitrate tolerance: the lack of effect of N-acetylcysteine","volume":"76","author":"Parker","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM198709243171304","article-title":"Prevention and reversal of nitrate tolerance in patients with congestive heart failure","volume":"317","author":"Packer","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib161","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/hrt.66.2.151","article-title":"Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate","volume":"66","author":"Fox","year":"1991","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib162","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(94)00416-N","article-title":"Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period","volume":"25","author":"Freedman","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib163","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-120-5-199403010-00001","article-title":"Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate","volume":"120","author":"Thadani","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib164","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.CIR.68.5.1074","article-title":"Tolerance to isosorbide dinitrate: rate of development and reversal","volume":"68","author":"Parker","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib165","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.jvca.2013.02.005","article-title":"Methemoglobinemia: a review and recommendations for management","volume":"28","author":"Cortazzo","year":"2014","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jacc.2017.09.1064_bib166","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2165\/00002018-199614060-00005","article-title":"Drug-induced methaemoglobinaemia. Treatment issues","volume":"14","author":"Coleman","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2017.09.1064_bib167","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9149(85)90324-8","article-title":"Association of methemoglobinemia and intravenous nitroglycerin administration","volume":"55","author":"Kaplan","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib168","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: A clinical concepts review","volume":"30","author":"Hottinger","year":"2014","journal-title":"J\u00a0Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib169","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/occmed\/kqh020","article-title":"The treatment of cyanide poisoning","volume":"54","author":"Cummings","year":"2004","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.jacc.2017.09.1064_bib170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5662\/wjm.v5.i2.88","article-title":"Past, present and future of cyanide antagonism research: From the early remedies to the current therapies","volume":"5","author":"Petrikovics","year":"2015","journal-title":"World J Methodol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib171","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/15563650.2012.742197","article-title":"Hydroxocobalamin in cyanide poisoning","volume":"50","author":"Thompson","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jacc.2017.09.1064_bib172","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1021\/jm7011497","article-title":"Novel, orally effective cyanide antidotes","volume":"50","author":"Nagasawa","year":"2007","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib173","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1213\/ANE.0b013e31824c4eb5","article-title":"Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium","volume":"114","author":"Belani","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2017.09.1064_bib174","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1161\/01.CIR.0000146906.42375.D3","article-title":"Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction","volume":"110","author":"Kloner","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib175","doi-asserted-by":"crossref","first-page":"85M","DOI":"10.1016\/j.amjcard.2005.12.018","article-title":"Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib176","first-page":"27","article-title":"Right ventricular myocardial infarction: from pathophysiology to prognosis","volume":"18","author":"Ondrus","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib177","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5114\/aoms.2015.47096","article-title":"Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy","volume":"11","author":"Zemanek","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jacc.2017.09.1064_bib178","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.117.303776","article-title":"Contemporary approaches to modulating the nitric oxide-cGMP pathway in cardiovascular disease","volume":"120","author":"Kraehling","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib179","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00441-008-0659-8","article-title":"Caveolae and transcytosis in endothelial cells: role in atherosclerosis","volume":"335","author":"Frank","year":"2009","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib180","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/01.RES.0000129178.56294.17","article-title":"Caveolae and caveolins in the cardiovascular system","volume":"94","author":"Gratton","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2017.09.1064_bib181","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1172\/JCI27100","article-title":"Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels","volume":"116","author":"Yu","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib182","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib183","doi-asserted-by":"crossref","first-page":"25437","DOI":"10.1074\/jbc.272.41.25437","article-title":"Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in\u00a0vivo","volume":"272","author":"Garc\u00eda-Carde\u00f1a","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib184","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1074\/jbc.272.30.18522","article-title":"Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity","volume":"272","author":"Ju","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib185","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1172\/JCI44778","article-title":"A\u00a0noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice","volume":"121","author":"Bernatchez","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2017.09.1064_bib186","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/HYPERTENSIONAHA.116.08171","article-title":"Modulating vascular hemodynamics with an alpha globin mimetic peptide (Hb\u03b1X)","volume":"68","author":"Keller","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2017.09.1064_bib187","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature11626","article-title":"Endothelial cell expression of haemoglobin \u03b1 regulates nitric oxide signalling","volume":"491","author":"Straub","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2017.09.1064_bib188","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/ATVBAHA.114.303974","article-title":"Hemoglobin \u03b1\/eNOS coupling at myoendothelial junctions is required for nitric oxide scavenging during vasoconstriction","volume":"34","author":"Straub","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib189","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.107.128009","article-title":"Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"325","author":"Wohlfart","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2017.09.1064_bib190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2015.02.020","article-title":"AVE 3085, a novel endothelial nitric oxide synthase enhancer, attenuates cardiac remodeling in mice through the Smad signaling pathway","volume":"570","author":"Chen","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jacc.2017.09.1064_bib191","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/CIRCULATIONAHA.107.717702","article-title":"Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction","volume":"118","author":"Fraccarollo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib192","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.TP.0000157364.80712.45","article-title":"Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction","volume":"79","author":"Ramzy","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib193","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib194","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1073\/pnas.79.9.2870","article-title":"Activation of\u00a0purified soluble guanylate cyclase by protoporphyrin IX","volume":"79","author":"Ignarro","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2017.09.1064_bib195","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226","article-title":"YC-1, a novel activator of platelet guanylate cyclase","volume":"84","author":"Ko","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2017.09.1064_bib196","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/0091270008319793","article-title":"Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: an ascending-dose study in healthy male volunteers","volume":"48","author":"Frey","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib197","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib198","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.09.1064_bib199","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/164_2016_100","article-title":"Novel sGC stimulators and sGC activators for the treatment of heart failure","volume":"243","author":"Breitenstein","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib200","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.09.1064_bib201","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2017.09.1064_bib202","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ab.2004.12.025","article-title":"A\u00a0cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide\/cGMP pathway","volume":"339","author":"Wunder","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jacc.2017.09.1064_bib203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.09.1064_bib204","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/eurjhf\/hfs093","article-title":"Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes","volume":"14","author":"Gheorghiade","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.09.1064_bib205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0005-2744(72)90060-5","article-title":"Separation of multiple molecular forms of cyclic adenosine-3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis","volume":"284","author":"Uzunov","year":"1972","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2017.09.1064_bib206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11897-016-0277-9","article-title":"The nitrate-nitrite-NO pathway and its implications for heart failure and preserved ejection fraction","volume":"13","author":"Chirinos","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2017.09.1064_bib207","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.107.719591","article-title":"Hypoxic modulation of exogenous nitrite-induced vasodilation in humans","volume":"117","author":"Maher","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.09.1064_bib208","first-page":"9","article-title":"Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation","volume":"171","author":"Modin","year":"2001","journal-title":"Acta Physiol Scand"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717408977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717408977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:14:23Z","timestamp":1760015663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717408977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":208,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0735109717408977"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1064","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}